Usana Health Sciences Inc
USNA
Market Cap$871.6M
Close$
$63.98
48.8% upside
Current Fair Value
48.8% upsideUndervalued by 48.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $871.60 Million |
|---|---|
| Enterprise Value | $541.96 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $3.3 |
| Beta | 0.93 |
| Outstanding Shares | 19,240,514 |
| Avg 30 Day Volume | 99,549 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 13.66 |
|---|---|
| PEG | 44.03 |
| Price to Sales | 0.92 |
| Price to Book Ratio | 1.72 |
| Enterprise Value to Revenue | 0.59 |
| Enterprise Value to EBIT | 5.82 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Usana Health Sciences Inc
CEO: Kevin Guest